Maxion Therapeutics
Maxion® Therapeutics | Home
Cambridge, United Kingdom · Founded 2020 · $88.0M raised
- Headquarters
- Cambridge
- Employees
- 11–50
- Founded
- 2020
- Business Model
- B2B
- Website
- maxiontherapeutics.com
- Total Funding
- $88.0M
- Last Round
- $72.0M Series AMar 2025
- Rounds
- 2
About
Biotech developing antibody-based KnotBody therapeutics targeting ion channels and GPCRs to treat autoimmune, pain, and cardiovascular diseases.
Summary
Maxion Therapeutics is a Life Sciences company based in Cambridge, United Kingdom, founded in 2020. It has raised $88.0M in total across 2 rounds, most recently a $72.0M Series A round in Mar 2025. Investors include LifeArc, Monograph Capital and BGF.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Mar 2025
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...